Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

March 31, 2000

Primary Completion Date

September 30, 2000

Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG

rubitecan

Trial Locations (13)

21079

Centre de Lute Contre le Cancer,Georges-Francois Leclerc, Dijon

28041

Hospital Universitario 12 de Octubre, Madrid

35062

Centre Eugene Marquis, Rennes

35128

Azienda Ospedaliera di Padova, Padua

44805

CRLCC Nantes - Atlantique, Nantes-Saint Herblain

63011

Centre Jean Perrin, Clermont-Ferrand

69373

Centre Leon Berard, Lyon

76038

Centre Henri Becquerel, Rouen

B-2650

Universitair Ziekenhuis Antwerpen, Edegem

F-94805

Institut Gustave Roussy, Villejuif

1117 MB

Academisch Ziekenhuis der Vrije Universiteit, Amsterdam

CH-6500

Ospedale San Giovanni, Bellinzona

Ch-1272

Clinique De Genolier, Genolier

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00005826 - Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme | Biotech Hunter | Biotech Hunter